About
Holostem develops, produces, registers, and distributes advanced therapeutic medicinal products based on epithelial stem cell cultures for cell and gene therapy applications, including treatments for severe ocular burns and genetic skin diseases such as epidermolysis bullosa.
Explore Holostem's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.